{"article": [{"url": "https://stocknews.com/news/bmy-chart-of-the-day-bristol-myers-squibb-bmy/", "published": 1596024500.0, "headline": "Chart of the Day: Bristol-Myers Squibb (BMY)", "body": "Bristol-Myers Squibb (BMY) is trading sideways, within a range, and a rectangle pattern has formed that could lead to a breakout or breakdown sometime soon. BMY discovers, develops, and markets drugs for various indications, such as cardiovascular, oncology, and immune disorders. The company\u2019s immuno-oncology drug, Opdivo, and its blood thinner, Eliquis, drive growth for the company\u2019s profits. The label expansion of Opdivo should continue to boost revenue. Take a look at the 1-year chart of Bristol BMY below with added notations: 9 \"BUY THE DIP\" Growth Stocks For 2020 Chart of BMY provided by TradingView After a very volatile spring, BMY has moved into a trading range and has formed a key resistance around $61 (red), and an important area of support around $57 (green). At some point, the stock will have to break either above the $61 or below the $57 mark. A trade could look to buy BMY when it exceeds $61, with the assumption of a breakout. Or short BMY if it falls below $57, with the assumption of a breakdown. Keep an eye out on August 6th for BMY\u2019s latest earnings report. Have a great trading day! Good luck! Christian Tharp, CMT @cmtstockcoach Want More Great Investing Ideas? 5 WINNING Stock Charts 9 \u201cBUY THE DIP\u201d Growth Stocks for 2020 Newly REVISED 2020 Stock Market Outlook 7 \u201cSafe-Haven\u201d Dividend Stocks for Turbulent Times BMY shares were trading at $58.82 per share on Wednesday morning, down $0.61 (-1.03%). Year-to-date, BMY has declined -6.25%, versus a 1.47% rise in the benchmark S&P 500 index during the same period."}]}